Meldonium
Cardioprotective, anti-anginal and anti-hypoxic agent improving metabolism and energy supply in cells.
Product Catalog - page 12
Mannitol
Solution for infusion. It facilitates rapid removal of fluids from the bloodstream, increases renal blood flow, thereby decreasing renal tissue hypoxia.
Maxicin®
Concentrate solution for infusion in dark glass vials.
How supplied
400 mg/20 ml, solvent included.
Longocain® Heavy
Potent long-acting anaesthetic for spinal anaesthesia.
5.0 ml vials;
5.0 ml pre-filled syringes.
How supplied:
5.0 ml ampoules;5.0 ml vials;
5.0 ml pre-filled syringes.
Longocain® 5 mg/ml
Potent long-acting anaesthetic for infiltration, conduction and epidural anaesthesia.
How supplied:
5.0 ml ampoules; 5.0 ml vials; 20.0 vials; 50.0 ml vials.
Longocain® 2,5 mg/ml
Potent long-acting anaesthetic for infiltration, conduction, spinal and epidural anaesthesia. Anaesthetic effect occurs rapidly (within 5–10 minutes) and lasts for 6–8 hours.
Linelid®
Linezolid is the first and only marketed oxazolidinone approved for clinical use.
300 ml (600 mg) polymer containers.
How supplied:
300 ml (600 mg) glass vials;300 ml (600 mg) polymer containers.
Lactuvit®
Natural laxative for regular bowel movement! Lactulose is the active substance in LACTUVIT®. It is a milk sugar produced from whey. Its natural origin has become the key to safe and wide administration of LACTUVIT® both in adults and in children from the first days of life.
Xylat®
Infusion therapy for diabetes mellitus and ketosis of different nature. Xylitol is a pentahydric alcohol with insulin-dependent utilization; it does not affect blood glucose levels, promotes secretion of endogenous insulin. It has the most pronounced antiketogenic effect among all carbohydrates and sugar alcohols.
Aminocaproic acid
Inhibits fibrinolysis by blocking plasminogen activators and partially inactivating plasmin.
Potassium Chloride
Concentrate for solution for infusion 7.5%.
How supplied:
10 ml, 20 ml glass vials or containers.
Infulgan®
The most prescribed analgesic in Europe: it is prescribed to 78 % of postoperative patients.